The current status of blood pressure control among patients with hypertension: A survey of actual clinical practice

Journal of Nippon Medical School

Volumn 79, Issue 1, 2012, Pages 69-78

  Hatori, Nobuo ^a   Sato, Kazuyoshi ^a   Miyakawa, Masaaki ^a   Mitani, Kazuhiko ^a   Miyajima, Masayuki ^a   Yuasa, Shouhei ^a   Furuki, Takamoto ^a   Matsuba, Ikuro ^a   Naka, Keiichi ^a  

^a Kobayashi Hospital   (Japan)

Author keywords

Blood pressure; Guidelines; Physicians

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRACTICE GUIDELINE; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; JAPAN; MALE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84863142825     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.79.69     Document Type: Article

References (28)

1. Antikainen R, Jousilahti P, Tuomilehto J: Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population. J Hypertens 1998; 16: 577-583.
2. Lida M, Ueda K, Okayama A, et al.: Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese-Nippon data 80. J Hum Hypertens 2003; 17: 851-857.
3. Kikuya M, Hozawa A, Ohokubo T, et al.: Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36: 901-906.
4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
5. Mechanic D, McAlpine DD, Rosenthal M: Are patients' office visits with physicians getting shorter? N Engl J Med 2001; 344: 198-204.
6. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP: A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 2001; 323: 75-81.
7. Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153: 598-615.
8. Zanchetti A, Hansson L, Clement D, et al.: Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? J Hypertens 2003; 21: 797-804.
9. Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
10. Mancia G, De Backer G, Dominiczak A, et al.: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
11. Whitworth JA: 2003 World Health Organization (WHO) International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
12. Japanese Society of Hypertension: Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res 2006; 29 Suppl: S1-105.
13. Ogihara T, Kikuchi K, Matsuoka H, et al.: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
14. Bobrie G, Chatellier G, Genes N, et al.: Cardiovascular prognosis of masked hypertension detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342-1349.
15. Ohkubo T, Asayama K, Kikuya M, et al.: How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens 2004; 22: 1099-1104.
16. Cappuccio FP, Kerry SM, Forbes L, Donald A: Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ 2004; 329: 145.
17. Fahey T, Schroeder K, Ebrahim S: Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 2005; 25: CD005182.
18. Mochizuki S, Dahlof B, Shimizu M, et al.: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 2007; 369: 1431-1439.
19. Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension: Guidelines for the management of hypertension for general practitioners. Hypertens res 2001; 24: 613-634.
20. Hansson L, Zanchetti A, Carruthers SG, et al.: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755-1762.
21. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
22. Berlowitz DR, Ash AS, Hickey EC, Glickman M, Friedman R, Kader B: Hypertension management in patients with diabetes: the need for more aggressive therapy. Diabetes Care 2003; 26: 355-359.
23. Ekpo EB, Shah IU, Fernando MU, White AD: Isolated systolic hypertension in the elderly: survey of practitioners' attitude and management. Gerontology 1993; 39: 207-214.
24. Miller NH, Hill M, Kottke T, Ockene IS: The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997; 95: 1085-1090.
25. Pellegrini F, Belfiglio M, De Berardis G, et al.: Role of organizational factors in poor blood pressure control in patients with type 2 diabetes: the QuED Study Group-quality of care and outcomes in type 2 diabetes. Arch Intern Med 2003; 163: 473-480.
26. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J: Predictors of uncontrolled hypertension in ambulatory patients. Hypertension 2001; 38: 809-814.
27. Yokokawa H, Goto A, Sanada H, Watanabe T, Yasumura S: Gaps between hypertension treatment guidelines and clinical practice in Japan: Baseline survey results from Fukushima Research of Hypertension (FRESH). J Clin Hypertens 2009; 11: 333-341.
28. Yokokawa H, Goto A, Sanada H, et al.: Achievement Status toward Goal Blood Pressure Levels and Healthy Lifestyles among Japanese Hypertensive Patients; Cross-sectional Survey Results from Fukushima Research of Hypertension (FRESH). Intern Med 2011; 50: 1149-1156.